Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alaunos Therapeutics, Inc.ZIOP · Entity 8339 | Director | December 29, 2017 | January 03, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alaunos Therapeutics, Inc.
Report date December 29, 2017 · Filed January 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,620 |
Ending reported balance
After 2017-12-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-12-29 · Grant · Acquired 17,258 · Balance 79,433 F1: 17,258 shares vest on 12/29/2018. Row 2 · 2017-12-30 · Tax withholding · Disposed 6,813 · Balance 72,620 F2: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants. |
Filing footnotes · ownership attribution and instrument terms
F1: 17,258 shares vest on 12/29/2018.
F2: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2017 Filed Jan 3, 2018 21:52 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 6,813 | $4.14 | $28,205.82 |
DisclosureSEC source: 0001209191-18-000980 · doc4.xml · nonDerivative · entry 2 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,620 F2 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 21:52 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | GrantCommon Stock | 17,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-000980 · doc4.xml · nonDerivative · entry 1 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,433 F1 · shares: 17,258 shares vest on 12/29/2018. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 21:41 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001209191-17-062374 · doc4.xml · derivative · entry 3 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 6,667 shares vested on each of 12/12/08 and 12/12/09; 6,666 shares vested on 12/12/10. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 21:41 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 12,639 | $4.32 | $54,600.48 |
DisclosureSEC source: 0001209191-17-062374 · doc4.xml · nonDerivative · entry 2 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,175 F1 · shares: Represents shares withheld to pay exercise price. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 21:41 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionCommon Stock | 20,000 | $2.73 | $54,600.00 |
DisclosureSEC source: 0001209191-17-062374 · doc4.xml · nonDerivative · entry 1 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:32 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001209191-17-039840 · doc4.xml · derivative · entry 3 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 5,000 shares vested and became exercisable on each of 6/18/08, 6/18/09 and 6/18/10. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:32 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 13,300 | $5.47 | $72,751.00 |
DisclosureSEC source: 0001209191-17-039840 · doc4.xml · nonDerivative · entry 2 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,814 F1 · shares: Represents shares withheld to pay exercise price. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:32 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionCommon Stock | 15,000 | $4.85 | $72,750.00 |
DisclosureSEC source: 0001209191-17-039840 · doc4.xml · nonDerivative · entry 1 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:34 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 10,558 | $5.35 | $56,485.30 |
DisclosureSEC source: 0001209191-17-000942 · doc4.xml · nonDerivative · entry 2 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,114 F2 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:34 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | GrantCommon Stock | 17,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000942 · doc4.xml · nonDerivative · entry 1 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,672 F1 · shares: 17,204 shares vest on 12/30/2017. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 21:30 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001209191-16-152302 · doc4.xml · derivative · entry 3 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2016-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 5,000 shares previously vested on each of 12/13/07, 12/13/08 and 12/13/09. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 21:30 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Tax withholdingCommon Stock | 13,483 | $7.22 | $97,347.26 |
DisclosureSEC source: 0001209191-16-152302 · doc4.xml · nonDerivative · entry 2 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,468 F1 · shares: Represents shares withheld to pay the exercise price. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 21:30 UTC | Alaunos Therapeutics, Inc. ZIOP · Entity 8339 | Exercise / conversionCommon Stock | 15,000 | $6.49 | $97,350.00 |
DisclosureSEC source: 0001209191-16-152302 · doc4.xml · nonDerivative · entry 1 BRENNAN MURRAY · CIK 0001338535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.